glp-1 news 2025 october 9 Body-wide multi-omic counteraction of aging with GLP-1R agonism: Cell Metabolism Repositioning GLP-1 Drugs for Neurologic

Blue Cross Blue Shield may cover Mounjaro for Type 2 diabetes with prior authorization but not necessarily for weight loss.

Clinically, that translates to: More stable post-meal glucose Better appetite regulation Reduced energy crashes Improved satiety Mechanistically: GLP-1 slows gastric emptying, signals fullness centrally, supports insulin secretion, and suppresses glucagon

Transition off GLP-1 meds like semaglutide with a strategic plan at Refine by Tulsi

Despite eating healthy and working out, lasting weight loss

The patient was a 44-year-old male with severe morbid obesity, heart failure, oxygen-dependent obesity hypoventilation syndrome, uncontrolled hypertension, anemia, and depression

Methods A systematic search was conducted across PubMed, Scopus, and Web of Science for studies assessing the impact of GLP-1RAs on WR after bariatric surgery